Substance Misuse and Family Violence Treatment Fathers
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexMale
Age18+
SponsorYale University
About this trial
This study involves a randomized controlled trial of Fathers for Change (F4C) compared to Individual Drug Counseling (IDC) with a sample of 280 fathers enrolled in substance use (SU) treatment within community or veterans (VA) healthcare settings to (a) demonstrate F4C efficacy compared to IDC in reducing SU and family violence (FV) at end of treatment, 3- and 6-month post-treatment follow-up, and (b) document improved emotion regulation as the mechanism within F4C that results in reduced SU and FV.
Eligibility criteria
Qualifiers
meet DSM-5 criteria for an SU disorder at the time of assessment at APT or VACHS;
report FV within the last 18 months prior to screening (based on self, court, police or child protection reports);
have at least one biological child aged 1 to 12 years with whom they live or have at least twice per month in person visits;
are able to complete assessments in English; and
Disqualifiers
an active full/no contact protective order pertaining to their child;
physiological addiction to a substance that requires detoxification (such individuals may be re-evaluated following detox);
cognitive impairment (a mini mental state score <25);
current untreated psychotic/bipolar disorder;
Trial design
Treatments tested in this trial
- Fathers for Change (F4C)
- Individual Drug Counseling (IDC)
Treatment groups
280 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yale University
Lead sponsor
APT Foundation, Inc.
Collaborator
VA Connecticut Healthcare System
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov